Ronald A. DePinho 13D and 13G filings for Tvardi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 5:30 pm Sale | 2025-12-31 | 13G | TVARDI THERAPEUTICS INC PA TVRD | Ronald A. DePinho | 426,190 4.500% | -200,000 (-31.94%) | Filing |